Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:915 (15 April), doi:10.1136/bmj.332.7546.915-a
EDITORHooper et al's conclusions that omega 3 fats have no effect on total mortality, combined cardiovascular events, or cancer are somewhat misleading.1
Firstly, their null findings could be partly explained by the use of the composite end points. They ignore strong biological evidence for the potentially disease specific effects of omega 3 fat. The underlying hypotheses for this study are not clearly stated for the main analyses. Systematic reviews have been published of the effect on mortality from coronary heart disease of long chain omega 3 polyunsaturated fatty acids in randomised controlled trials and fish in prospective cohort studies.2 3
Secondly, the authors focus primarily on the summary estimates from heterogeneous studies.
Thirdly, Hooper et al exclude 108 potential cohorts that have no omega 3 assessment. Dietary intake of long chain omega 3 fatty acids assessed by dietary instruments is more likely to be a surrogate marker of fish consumption. The effects of dietary long chain omega 3 fatty acid intake cannot be isolated from fish intake. In observational studies, the focus should therefore be on fish consumption rather than intake of long chain omega 3 fatty acid. Hooper et al also compare the most exposed quantile with the least exposed quantile. Since the amounts of omega 3 intake substantially varied between these two extreme groups across individual studies, the combined results may differ depending on the range of omega 3 intake and number of exposure groups in the primary studies.
Fourthly, the authors do not provide data for exploring any dose-response relation or possible threshold for the effects of omega 3 fats on different end points of interest. Neither do they provide further evidence to justify the sufficiency and robustness of their results.
Finally, their study does not distinguish between primary prevention and secondary prevention by omega 3 fatty acids. Mixing them together could lead to misinterpretation of the results.
Ka He, assistant professor
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 North Lake Shore Drive, Suite 1102, Chicago, IL 60611, USA kahe{at}northwestern.edu
Yiqing Song, instructor
Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, USA
What can you learn from this BMJ paper? Read Leanne Tite's Paper+